Topiol Sid
CSO, 3D-2drug, LLC; Professor and Director,
Microbiology
Biotech Umea
Sweden
Biography
Sid Topiol received his B.S. from CCNY and his Ph.D. from NYU. He trained as a theoretical quantum chemist. He post-docked at Northwestern with Mark Ratner and Arthur Frost, and at Carnegie-Mellon with John Pople (Noble laureate.) He first joined The Mount Sinai School of Medicine in the Department of Pharmacology. He has spent over 20 years in Pharma, starting with Berlex followed by Sandoz/Novartis and then Lundbeck. He has worked on all aspects of Structural and Computer Aided Drug Discovery in interdisciplinary project environments. He now engages in industrial and academic activities. In 2010 he formed 3D-2Drug, a consulting company which provides the means for the most efficient drug discovery activities through advanced scientific approaches.
Research Interest
he began teaching as an Adjunct Lecturer at New Jersey Institute of Technology and has, in 2014, joined the newly forming Center for Healthcare Innovation at the Stevens Institute of Technology.
